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ABSTRACT
Ribonucleoside 5′-monophosphates (rNMPs) are the
most common non-standard nucleotides found in
DNA of eukaryotic cells, with over 100 million rNMPs
transiently incorporated in the mammalian genome
per cell cycle. Human ribonuclease (RNase) H2 is
the principal enzyme able to cleave rNMPs in DNA.
Whether RNase H2 may process abasic or oxidized
rNMPs incorporated in DNA is unknown. The base
excision repair (BER) pathway is mainly responsible
for repairing oxidized and abasic sites into DNA. Here
we show that human RNase H2 is unable to process
an abasic rNMP (rAP site) or a ribose 8oxoG (r8oxoG)
site embedded in DNA. On the contrary, we found that
recombinant purified human apurinic/apyrimidinic
endonuclease-1 (APE1) and APE1 from human cell
extracts efficiently process an rAP site in DNA and
have weak endoribonuclease and 3′-exonuclease ac-
tivities on r8oxoG substrate. Using biochemical as-
says, our results provide evidence of a human en-
zyme able to recognize and process abasic and oxi-
dized ribonucleotides embedded in DNA.
INTRODUCTION
Incorporation of ribonucleotidesmonophosphate (rNMPs)
in DNA is a frequent phenomenon, which is considered the
most common type of ‘DNA damage’ occurring in normal
cells (1,2). Ribose-seq and other approaches recently de-
veloped for mapping sites of rNMPs in DNA have shown
widespread but not random distribution of rNMPs in chro-
mosomal DNA of budding and fission yeast (2) (and ref-
erences therein). The number of rNMPs identified per nu-
clear chromosomewas found to be proportional to chromo-
some size (2), and quantitation approaches have estimated
a 600,000 rNMPs in budding yeast genome and over 100
millions in mouse genome (3).
The incorporation of rNMPs in genomic DNA may be
due to: (i) the disequilibrium in the cellular pool of deoxyri-
bonucleotides (dNTPs) and ribonucleotides (rNTPs) (2),
(ii) an incomplete elimination of RNA primers used in the
generation of Okazaki fragments (4), (iii) an oxidation of
the deoxyribose sugar into ribose (5) and last but not least,
(iv) an imprecise 3′-exonucleolytic proofreading activity of
replicative DNA polymerases, which do not discriminate
rNMPs from dNMPs pool (2,4,6,7). Furthermore, taking
into consideration all rNMPs that are synthesized during
lagging strand synthesis, more than 100 million rNMPs are
introduced into themammalian genome per cell cycle (3). In
addition, it has been estimated that the amount of rNTPs is
generally 40–350-fold higher than that of dNTPs in cycling
cells (6–8) increasing the probability of incorrect rNMP in-
corporation during DNA replication and repair (2,4,6,7).
The effects of the 2′-hydroxyl group of the ribose sugar
within an rNMP embedded in DNA are numerous: it
mainly altersDNA elasticity and structure in a sequence de-
pendentmanner (9–11) and affects the activity and function
of several DNA-interacting proteins, in addition to increase
the DNA fragility and mutability (1,12). Moreover, rNMPs
in DNA can be template for DNA synthesis (13,14), al-
though the DNA polymerases processivity on rNMP tracts
is reduced (13).
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The main pathway deputed to rNMPs removal is ribonu-
cleotide excision repair (RER), in which the principal en-
zyme is RNase H2. It was demonstrated that RNase H2
deficiency in mammalian cells is associated to DNA dam-
age repair activation and, in humans, to pathology. RNase
H2-null murine embryonic fibroblasts (MEFs) activate a
p53-dependent damage response, whereas null-RNase H2
are embryonic lethal (15). In humans, mutations in each
of the three subunits of RNase H2 are associated with the
neurological syndrome of Aicardi-Goutie`res (AGS), which
causes severe brain dysfunction (16–18). Altered RNase H2
function in AGS patients may result in increased level of
rNMPs in DNA, which could in turn activate DNA dam-
age response signaling and induce innate immune response
(19,20).
Besides RER, other different DNA repair mechanisms
are active to remove rNMPs embedded in DNA (3,21). In
the absence of RNase H2, topoisomerase I cleavage (21),
followed by nick processing by Srs2–Exo1, can remove some
rNMPs (22,23). rNMPs in DNA can be also targeted by
the nucleotide excision repair (NER) factors in bacteria
(24). However, in vitro experiments showed that human
NERproteins are not active to remove rNMPs embedded in
DNA (25). Differently, the mismatch repair (MMR) mech-
anism targets mismatches with rNMPs both in Escherichia
coli and Saccharomyces cerevisiae genomicDNA (26). Until
now, there is no proof that the base excision repair (BER)
mechanism plays any role in removing rNMPs from DNA.
BER is known to repair a wide spectrum of oxidative le-
sions in nuclear and mitochondrial DNA (27,28), and pre-
venting cancer (29,30). Abasic sites, which form by sponta-
neous hydrolysis of the N-glycosidic bond in DNA or fol-
lowing removal of a damaged base by BER glycosylases, are
major targets or intermediate substrates in the BER path-
way of DNA repair (31). It has been estimated that up to
10,000 abasic sites are formed per human genome per day
(32). Despite the fact that spontaneous depurination oc-
curs ∼1,000 times slower in RNA than DNA (33), due to
the high abundance of rNMPs in genomes, with >100 mil-
lion rNMPs transiently present inmammalianDNAduring
one replication cycle, considering rNMP incorporation by
DNA polymerases during DNA replication and repair, and
RNA primers of Okazaki fragments (3), the possibility that
abasic and oxidized rNMPs (such as 7,8-dihydro-8-oxo-
riboguanosine) are present in DNA and are targets of BER
is quite real and worth careful study. These data, together
with other recent findings about the ability of Schizosaccha-
romyces pombe Pol 4,Mycobacterium smegmatisDinB2 and
human Pol to insert and elongate oxidized rGMP when
paired with dA during DNA replication (34–36), under-
score the necessity to determine how cells can target and
remove oxidized rNMPs or rAP sites from DNA.
Because recent studies point toward a new function of
BER in RNA surveillance (37,38), there is high likelihood
that BER could be involved in the processing of rNMPs
in DNA, particularly in the case of chemically modified
rNMPs, such as abasic and oxidized rNMPs. Identifying
whether BER may target normal and modified rNMPs in
DNA is important to better understanding the mechanism
of genotoxicity of reactive oxygen species, the function and
the impact of BER defects in human disease and cancer
mechanisms. In the absence of proper repair mechanisms
to cope with these kind of lesions, even a single or a few
modified rNMPs present in a genome per cell cycle could
lead to mutations and/or genomic rearrangements.
Findings from our and other laboratories have revealed
an important involvement of the apurinic/apyrimidinic en-
donuclease 1 (APE1) in RNA metabolism and RNA-decay
(37–40). APE1 is by far one of the most studied enzymes
in the BER pathway for its altered expression in different
human pathologies ranging from neurodegenerative to can-
cer disorders (41). Its role in DNA repair is primarily due
to its ability to act as an endonuclease, specifically able to
cleave 5′ to deoxy- abasic sites, which results in a strand
break with 3′-hydroxyl and 5′-phosphodeoxyribose termini.
APE1 also has redox activity needed to modulate the DNA
binding ability of several transcription factors (41). As re-
cently demonstrated, APE1 can endonucleolytically cleave
abasic single-strandedRNA (37,38,40), has a 3′-RNAphos-
phatase activity, and a weak 3′-5′ exoribonuclease activity
(42). Moreover, it has been demonstrated that APE1 has
nucleotide incision repair (NIR) activity on modified bases,
such as 5,6-dihydro-2′-deoxyuridine, 5,6-dihydrothymidine,
5-hydroxy-2′-deoxyuridine, 5-hydroxycytosine, which are
directly repaired by APE1 bypassing the action of specific
glycosylases (43–45). Therefore, we hypothesized thatAPE1
can be involved in processing rNMPs in DNA, particularly
in the case of abasic and oxidized rNMPs.
Here, we found that eukaryotic RNase H2 from yeast,
mouse and human is inactive on an rAP site in DNA in
different assays. We discovered and characterized an un-
known APE1 activity on abasic ribonucleotide embedded
in DNA. We then compared the ability of human RNase
H2 to cleave at an oxidized ribonucleotide (r8oxoG) incor-
porated in a DNA substrate and analyzed the activities of
8-oxoguanine DNA glycosylase (OGG1) and APE1 to rec-
ognize and cleave this particular type of damage. Our data
demonstrate that APE1, but not human RNase H2 and
OGG1, has a weak endoribonuclease activity on the oxi-
dized substrate.
MATERIALS AND METHODS
Double strand synthetic oligonucleotides description and an-
nealing conditions
All oligonucleotides and their complementary sequences
used in this study are listed in Supplementary Table S1
(see also Supplementary Figure S1). ss dG 40 oligonu-
cleotide and its reverse complementary sequence, ss dC 40,
were purchased from Invitrogen (Grand Island, NY, USA).
ss rG 40 oligonucleotide and the DNA oligo containing a
tetrahydrofuran abasic deoxyribonucleotide, ss dF 40, or
tetrahydrofuran abasic ribonucleotide, ss rF 40, as well as
ribo- 1′OH abasic containing oligonucleotide, ss rOH, were
purchased from Dharmacon (GE Healthcare, Lafayette,
CO, USA). The 26-mer oligonucleotide containing a
tetrahydrofuran, ss dF, and its reverse complementary se-
quence ss dC, were synthesized from Metabion Interna-
tional AG (Steinkirchen, Germany). The 25-mer dG-, rG-,
d8oxoG-containing oligonucleotides and complementary
oligonucleotides were synthesized from Metabion Interna-
tional AG (Steinkirchen, Germany).
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ss dG 40, ss rG 40, ss dF 40 and ss rF 40 oligonu-
cleotides were 5′ end-labeled with [ -32P] ATP
(PerkinElmer, Boston, MA, USA) by T4 polynucleotide
kinase (PNK) (New England BioLabs, Ipswich, MA,
USA) in a reaction mixture containing 10 M ATP using
10X PNK buffer (New England BioLabs, Ipswich, MA,
USA). This labeling reaction was incubated at 37◦C for 1 h,
followed by inactivation at 65◦C for 20 min. The reactions
were purified by using Illustra MicroSpin G-25 column
(GE Healthcare, Buckinghamshire, UK).
The remaining oligonucleotides were labelled with either
IRDye700, IRDye800 fluorophores or Cyanine5 at 5′ end,
as specified in Supplementary Table S1, purified through
RP-HPLC, checked in Mass Check and re-suspended in
RNase- and DNase- free water.
Synthesis of oligonucleotide containing an internal ri-
bose 8-oxo-guanosine (r8oxoG) and an IRDye700 fluo-
rophore at 5′ end was in-house carried out on an Ap-
plied Biosystems 392 DNA/RNA synthesizer using the
phosphoramidite chemistry, associated with the phenoxy-
acetyl protecting group for the nucleobases and the tertio-
butyldimethylsilyle protecting group at the 2′-OH position
of the ribonucleoside residue (46). Upon completion, the
oligonucleotide was de-protected in concentrated aqueous
ammonia for 6 h at 55◦C, followed by a desilylation step
with triethylamine trihydrofluoride (8 h at room tempera-
ture) (46) and was finally purified by preparative 20% de-
naturing PAGE using UV-shadowing detection. After de-
salting by size exclusion, the r8oxoG oligonucleotide was
quantified by UV measurements at 260 nm and its purity
was checked by RP-HPLC analysis together with MALDI-
TOF mass measurements (Supplementary Figure S5, pan-
els A and B). Sample was then lyophilized and frozen at –
20◦C until use.
All oligonucleotides used in the present study were re-
suspended in RNase- andDNase-free water at 100M. 100
pmol of each oligonucleotidewas annealedwith an excess of
150 pmol of its complementaryDNAoligonucleotide (as in-
dicated in Supplementary Table S1) in 10 mMTris–HCl pH
7.4 and 10 mM MgCl2, heated at 95◦C and cooling down
over night in the dark.
Plasmid and expression of recombinant proteins
Plasmids and expression of human recombinant OGG1 en-
zyme was purified as described by Audebert et al. (47). Plas-
mids and expression of human recombinant APE1 wild
type (WT) and respective mutants (APE1 N33 and APE1
E96A) were produced as explained by Fantini et al. (48) and
Erzberger andWilson (49). Plasmid and expression of yeast,
mouse and human recombinant RNase H2 were produced
as explained by Chon et al. (50,51).
Cell lines and silencing experiments
HeLa cells (human cervical carcinoma) (ATCC®, Milan,
Italy) were grown inDMEM(EuroClone,Milan, Italy) sup-
plemented with 10% fetal bovin serum (FBS-EuroClone,
Milan, Italy), penicillin (100 U/ml), streptomycin (100
mg/ml) and L-glutamine (2 mM) (EuroClone, Milan, Italy)
and cultured in a humidified incubator at 5% CO2 at 37◦C.
For silencing experiments, 15 × 104 cells were seeded and
transfected with 5′ UACUCCAGUCGUACCAGACCU 3′
siAPE1 (100 pmol) or siGENOME SMART pool siR-
Nase H2A (50 pmol) or 5′ CCA UGA GGU CAG CAU
GGU CUG UU 3′ scramble control siRNA (100 pmol)
(GE Dharmacon, Milan, Italy) by using Oligofectamine™
Reagent (GE Dharmacon, Milan, Italy) as per manufac-
turer’s indications. After 72 h upon transfection, cells were
harvested by trypsinization and centrifuged at 250 × g
for 5 min at 4◦C. Supernatant was removed, and pellet
was washed once with ice-cold phosphate-buffered saline
without Calcium and Magnesium (PBS-Euroclone, Milan,
Italy) and then centrifuged again (250× g for 5 min at 4◦C).
Preparation of nuclear cell extracts (NCE)
After washing with PBS, cells were collected in cold PBS
added with 0.1 M DTT and 0.5 mM phenylmethylsulfonyl
fluoride (PMSF). Cells were centrifuged at 800 × g for 10
min at 4◦C and the supernatant was removed. Pellet was
re-suspended in a cold hypotonic solution containing 10
mMHEPES pH 7.9, 10 mMKCl, 0.1 mMMgCl2, 0.1 mM
EDTA pH 8.0 complemented with 0.1 mM DTT, 0.5 mM
PMSF, 1 mM protease inhibitor (PI), 1 mM NaF, 1 mM
Na3VO4. After centrifugation at 800 × g for 10 min at 4◦C,
cytosolic proteins (CCE) were collected whereas intact nu-
clei were pelleted. Pellet was washed to discard any contam-
ination from cytosol and it was subsequently re-suspended
with a cold hypertonic solution 20 mMHEPES pH 7.9, 420
mMNaCl, 1.5mMMgCl2, 0.1mMEDTApH8.0, 5% glyc-
erol complemented with 0.1 mM DTT, 0.5 mM PMSF, 1
mM PI, 1 mM NaF, 1 mM Na3VO4 and incubated on ice
for 30 min. At the end, the sample was centrifuged at 15,000
× g for 20min at 4◦Cand collected the supernatant contain-
ing nuclear proteins (NCE). Quantification of each sample
was performed by colorimetric Bradford assays (Bio-Rad,
Milan, Italy).
Preparation of whole cell extracts (WCE)
After washing with PBS, cells were harvested by trypsiniza-
tion and centrifuged at 250× g for 5 min at 4◦C. The super-
natant was removed, washed oncewith PBS and centrifuged
again. Pellet was re-suspended in a lysis solution containing
50 mM Tris–HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA,
1% (w/v) Triton X-100 supplemented with 1 mM PI, 1 mM
DTT, 0.5 mMPMSF, 1mMNaF and 1mMNa3VO4. After
centrifugation at 15 000 × g for 20 min at 4◦C, the super-
natant is considered as whole cell extract (WCE). Proteins
of each sample were quantified using a colorimetric Brad-
ford assays (Bio-Rad, Milan, Italy).
Enzymatic activity assays
Tomeasure enzymatic activity of recombinant proteins and
NCE on different substrates, each reaction was prepared
following doses, time points and buffers specified in detail
into the legend of each experiment. Final volume for each
reaction was 10 l. At the end of all reactions, samples were
blocked with a stop solution, containing 99.5% (v/v) for-
mamide (Sigma-Aldrich, Milan, Italy) supplemented with
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10× Orange Loading Dye (Li-Cor Biosciences, Milan,
Italy) and heated at 95◦C for 5 min. Then, all samples were
loaded onto a 7 M denaturing 20% polyacrylamide gel in
TBE buffer pH 8.0 and run at 4◦Cat 300V for 1 h. Then, the
gel was visualized with an Odyssey CLx Infrared Imaging
system (LI-CORGmbH,Germany). The signals of the non-
incised substrate (S) and the incision product (P) bandswere
quantified using Image Studio software (LI-COR GmbH,
Germany). When using the ds rOH:dC and ds r8oxoG:dC
oligonucleotides, a very small amount of cleavage product
was seen in samples not treated with recombinant proteins
and/or cell extracts due to the reactivity of this molecule,
which was spontaneously degraded. During the analysis,
this band has been always subtracted from bands obtained
following treatment with recombinant proteins and/or ex-
tracts.
For radioactive experiments, reactions were stopped by
adding 2× denaturing PAGE gel buffer (0.01% bromophe-
nol blue, 95% formamide and 20 mM EDTA pH 8.0) and
heating to 95◦C for 5min. After dilutions, the products were
analyzed by 15% (w/v) polyacrylamide, 8 M urea gel elec-
trophoresis (urea–PAGE). 20–100 Oligonucleotide Length
Standard (Integrated Device Technology, Coralville, IA,
USA) was used as a ladder (M). After electrophoresis, gels
were exposed to phosphor screen overnight. Images were
taken with Typhoon Trio+ (GE Healthcare, Lafayette, CO,
USA) and obtained with ImageQuant (GE Healthcare).
Band intensities were quantified by Multi Gauge V3.0 (Fu-
jifilm).
Electrophoretic mobility shift assay analysis (EMSA)
Proteins binding to nucleic acids was assessed by EMSA
analysis as already described by Fantini et al. (48). Briefly,
the indicated amounts of recombinant purified proteins or
cell extracts were co-incubated with 250 fmol of the probe
(25 nM) at 37◦C for 30 min. Reactions were prepared in
a buffer containing 8 mM HEPES, 10 mM KCl, 400 M
EDTA pH 8.0, 5 mM DTT and 2% glycerol in a 10 l fi-
nal volume. Moreover, salmon sperm DNA (SSD) (Sigma-
Aldrich, Milan, Italy) was added like as DNA competi-
tor. Samples were loaded onto an 8% (w/v) native poly-
acrylamide gel in tris-sodium acetate–EDTA pH 8.0 (TAE)
buffer and run at 4◦C at 150 V for 1 h followed by 3 hat 250
V.
Statistical analysis
Statistical analyses were performed by using the Student’s t
test. P < 0.05 was considered as statistically significant.
RESULTS
Human, yeast or mouse RNase H2 does not process an rAP
site embedded in DNA
RNaseH2 is the principal protein able to process paired and
mismatched rNMP sites embedded in DNA by generating a
nick to their 5′ side (26) (and references therein). Up to now,
whether RNase H2 can cleave an rAP site incorporated in
a duplex DNA is unknown. In order to test this hypoth-
esis, we measured RNase H2 ability to cleave a modified
Figure 1. Scheme of substrates used to test cleavage of an rAP site inDNA.
DNA nucleotides are in blue, RNA in red. The 5′ and 3′ ends of eachDNA
strand are indicated. (A) Scheme of double strand (ds) DNA 25-mer sub-
strates (single strand (ss) oligonucleotide annealed to ss dC containing-
complementary oligonucleotide) containing a dGMP, rGMP, dF and 1′
OHabasic rNMP (rOH) site in the 13th position. The ‘IRD700’ in green in-
dicate IRDye 700 phosphoramidite dye tagged at the 5′ end. The ‘IRD800’
in green indicate IRDye 800 phosphoramidite dye tagged at the 5′ end. The
‘Cy5’ in green indicates cyanine dye tagged at the 5′-end of the top strand
of the duplex. (B) Scheme of the ds DNA 40-mer substrate (ss oligonu-
cleotide annealed to its ss complementary oligonucleotide) containing a
dGMP, rGMP, dF and rF site in the 20th position. The P in purple indi-
cates radiolabelled 32P at the 5′-end of the top strand of the duplex. The
red arrow indicates the cleavage position byRNaseH2 5′ to the rGMP site.
25-mer DNA oligonucleotide, called ds rOH:dC, in which
a 1′-OH abasic rNMP was incorporated into a DNA sub-
strate as shown in Figure 1A (see also Supplementary Table
S1 and Supplementary Figure S1). First of all, recombinant
human RNase H2, composed of its three subunits, was pu-
rified as explained in Materials and Methods (Supplemen-
tary Figure S2) and its activity was tested on ds rOH:dC
oligonucleotide in parallel with dG- and rG- containing
oligonucleotides as negative and positive controls, respec-
tively. As reported in Figure 2, the enzyme had no activ-
ity on ds dG:dC and ds dF:dC (containing a tetrahydro-
furan residue mimicking the abasic site) oligonucleotides,
whereas it efficiently cleaved the canonical rG substrate as
expected. In addition, we tested the mismatched rG- con-
taining oligonucleotide, ds rG:dA, confirming that RNase
H2 protein is also active on this type of substrate (Fig-
ure 2A). On the other hand, no activity was detectable on
ds rOH:dCdemonstrating that recombinant humanRNase
H2 is not able to process an abasic rNMP embedded in
DNA. To confirm these data in cells, we tested the activity
of RNase H2 protein obtained from nuclear cell extracts on
the same substrates, as above (Figure 2). To this aim, RNase
H2 expression was downregulated in HeLa cells through
specific siRNA and the endoribonuclease activities of nu-
clear extracts from knocked down and control cells were
then assayed. Western blotting analyses performed on nu-
clear extracts from control (Scramble) and knocked down
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Figure 2. Human RNase H2 is not able to process an rAP site embedded in a duplex DNA substrate. (A) Representative denaturing polyacrylamide gel
of oligonucleotides (25 nM) incision by recombinant human RNase H2 (0.5 nM). The reaction was performed in RNase H2-buffer (20 mM Tris–HCl, 25
mM KCl, 0.1% BSA, 0.01% Tween20, 4 mM MgCl2, pH 7.4) for different time points, expressed in minutes and shown on the top of the figure, at 37◦C.
ds dG:dC and ds dF:dC oligonucleotides were used as negative controls whereas paired and mismatched ds rG oligonucleotides as positive controls. S
indicates the substrate position while P indicates the product position (left). Relative graph illustrating the time-course kinetics activity of the recombinant
protein on ds rG:dC and ds rG:dA oligonucleotides. Data are expressed asmean± SDof three independent technical replicas (right). (B) Graph illustrating
the time-course kinetics activity of NCE on ds rG:dC in control and RNase H2-knocked down conditions. Enzymatic reaction was performed at 37◦C in
RNase H2-buffer with 500 ng of NCE. Data are expressed as mean ± SD of three independent technical replicas. Standard deviation values were always
less than 10% of the mean of the experimental points. (C) Graph illustrating the time-course kinetics activity of NCE on ds rOH:dC oligonucleotide in
control and RNase H2-knocked down conditions. Enzymatic reaction was performed at 37◦C in RNase H2-buffer with 500 ng of NCE. Data are expressed
as mean ± SD of three independent technical replicas. Standard deviation values were always less than 10% of the mean of the experimental points.
(siRNase H2) cells demonstrated the efficiency of RNase
H2 downregulation (∼50%) upon transfection with spe-
cific siRNA sequences (Supplementary Figure S3A). We
incubated Scramble or siRNase H2 cell extracts with dif-
ferent substrates for the indicated time points. Following
knock-down of RNase H2, we found a decreased cleavage
of ds rG:dC, as expected (Figure 2B and Supplementary
Figure S3B). Surprisingly, we found that ds rOH:dC was
also cleaved; however, ds rOH:dC cleavage was completely
unaffected by siRNase H2 cell extracts (Figure 2C and Sup-
plementary Figure S3B). These data suggest that while hu-
man RNase H2 is inactive on an abasic rNMP embedded
in DNA, there is another enzyme/s capable of cleaving it in
human cells.
To increase the stability of the abasic rNMP-containing
oligonucleotide, we also used abasic substrates mimicked by
tetrahydrofuran (F) residues, similarly to what commonly
used for dNMP (52,53). We then tested whether RNase H2
from yeast or mouse may process an abasic rNMP, mim-
icked by a tetrahydrofuran ribonucleotide residue, embed-
ded in a longer DNA sequence composed of 40-bp to eval-
uate a possible role of the length of the substrate in de-
termining the inability of RNase H2 to process these sub-
strates (Figure 1B). We used single-stranded (ss) or double-
stranded (ds) DNA substrates containing an abasic rNMP
site (rF), an rGMP (rG), an abasic dNMP (dF) or a dGMP
as internal controls (Supplementary Table S1). As expected,
S. cerevisiae and mouse RNase H2 cleaved at the single rG
in a DNA duplex substrate (lane 9 in Figure 3, panels A and
B, respectively) and had no activity on the rG embedded in
the ss substrate (lanes 7 and 8 in Figure 3, panels A and
B). Importantly, as we found for human RNase H2, also S.
Downloaded from https://academic.oup.com/nar/article-abstract/45/19/11193/4084662
by guest
on 08 January 2018
11198 Nucleic Acids Research, 2017, Vol. 45, No. 19
A 
B 
40 nt
30 nt
20 nt
19 nt
40 nt
30 nt
20 nt
19 nt
0 0 0 0 0 0 0 0 81 0 0 0enzymatic activity (%)
# lane M 1 2 3 4 5 6 7 8 9 10 11 12
Yeast RNase H2
- +
Mouse RNase H2
- +
0 0 0 0 0 0 0 0 54 0 0 0enzymatic activity (%)
# lane M 1 2 3 4 5 6 7 8 9 10 11 12
Figure 3. Mouse and yeast RNase H2 are not able to process an rAP site
embedded in a duplex DNA substrate. (A and B) Denaturing PAGE gels
showing cleavage result using 10 nM of 40-mer radioactive substrate con-
taining an rG or an rF site, without (lanes 1–6) or with (lanes 7–12) 10 nM
of yeast RNase H2 protein (A) or 10 nM of mouse RNase H2 protein (B).
All reactions were carried out at 37◦C for 1 h in yeast/mouse reaction 1×
buffer (15 mM Tris–HCl pH 8.0, 50 mM NaCl, 10 mM MgCl2, 5% glyc-
erol, 1 mM DTT and 0.1 mg/mL BSA). M indicates the DNA ladder and
the black arrows on the left of each panel show specific band sizes. Lanes
1,7 have ss-substrate containing rG (ss rG 40), lanes 2,8 have ss-substrate
containing ss rG 40 that is cooled slowly at room temperature to demon-
strate the absence of any self-annealing structures, and lanes 3,9 show the
ds-substrate containing rG (ds rG dC). Lanes 4,10 have ss-substrate con-
taining abasic ribo site (ss rF 40), lanes 5,11 have ss rF 40 that is cooled
slowly in room temperature to observe any self-annealing; and lanes 6,12
have ds substrate containing abasic ribo site (ds rF:dC). The percentages
of cleavage of each reaction are displayed below the images as enzymatic
activity (%).
cerevisiae andmouse RNase H2 complexes were inactive on
the abasic rNMP, ds rF:dC (lane 12 in Figure 3, panels A
and B). Together these results demonstrate the inability of
eukaryotic RNaseH2, both from yeast andmammalian ori-
gins, to process an abasic rNMP incorporated in DNA in-
dependently from the nature of the abasic site (either 1′-OH
or tetrahydrofuran residue) and the length of the substrate
(either 25- or 40-mers).
Human APE1 is able to process an rAP site embedded in
DNA through its endonuclease catalytic domain
To test the ability of APE1 to process rAP sites in DNA,
we purified human recombinant APE1 protein, as de-
scribed in Materials and Methods section (Supplemen-
tary Figure S4A). The endonuclease activity of APE1 on
ds rOH:dC substrate was examined through cleavage as-
says. As a positive control for APE1 endonuclease activ-
ity, an oligonucleotide substrate containing a tetrahydro-
furan residue mimicking the abasic site, called ds dF:dC
(52,53), was used. As reported in Figure 4A, and mea-
sured through kinetics experiments in Table 1, APE1 pro-
cesses the abasic rNMPas efficiently as the canonical deoxy-
abasic site having a lower affinity for the ds rOH:dC than
the ds dF:dC (11-fold increase of the KM) but a higher cat-
alytic rate (27-fold increase in the kcat/KM ratio) (Table 1).
Moreover, APE1 was unable to process the rG- contain-
ing oligonucleotide, which is the preferential substrate of
RNase H2 enzyme. To further characterize the enzymatic
activity of APE1, we used the purified recombinant mutant
APE1 E96A protein, in which the missense mutation of the
residue in the catalytic site, characterized by the substitution
of the glutamic acid in position 96 with alanine, causes a de-
creased enzymatic activity of the protein, lacking the ability
to coordinate the Mg2+ ion in the catalytic site (52,54,55)
(Supplementary Figure S4B). In addition, we used the puri-
fied recombinant mutant APE1N33 protein, in which the
first 33 N-terminal residues, responsible for RNA-protein
interaction but not affecting its enzymatic activity, have
been deleted (32,38) (Supplementary Figure S4B). Follow-
ing incubation of ds rOH:dC with APE1 E96A mutant,
there was barely any endonuclease activity, whereas the ac-
tivity of APE1 N33 mutant was comparable with that of
the APE1 WT protein (Figure 4, panels B and C and Sup-
plementary Figure S4C). These data demonstrate that the
catalytic domain of APE1 is responsible for recognizing and
cleaving a rAP site in dsDNA and that the N-terminal do-
main does not play any major role in the enzymatic activity
on this substrate and that AP endonucleolytic activity on
rAP sites is intrinsic to the purified protein.
Kinetic parameters (KM, VMAX and kCAT) were calcu-
lated from the measurement of the endonucleolytic reaction
rates for APE1 on ds dF:dC and ds rOH:dC substrates. As
described by Fantini et al. (48), increasing concentrations
of the substrate were incubated with a selecting concentra-
tion of the protein (see first column) in a time-course exper-
iment. Kinetic values were calculated using a Lineweaver–
Burk plot analysis and represent the mean ± SD of three
independent experiments.
To confirm that APE1 is the major enzyme capable
of cleaving ribo-abasic containing sites in cells, we used
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Figure 4. Human APE1 efficiently processes an rAP site embedded in a duplex DNA substrate. (A) Representative denaturing polyacrylamide gel of
oligonucleotides (0.25 M) incision by recombinant human APE1 (0.288 nM). The reaction was performed in APE1-buffer (20 mM Tris–HCl, 100 mM
KCl, 0.1% BSA, 0.01% Tween20, pH 7.4) for different time points, expressed in minutes and shown on the top of the figure, at 37◦C. ds dG:dC and
ds rG:dC oligonucleotides were used as negative controls, whereas ds dF:dC oligonucleotide as positive control. S indicates the substrate position, while P
indicates the product position (left). Relative graph illustrating the time-course kinetics activity of the recombinant protein on ds dF:dC and ds rOH:dC
oligonucleotides. Data are expressed as mean ± SD of three independent technical replicas. Standard deviation values were always <10% of the mean of
the experimental points (right). (B) Graph illustrating the time-course kinetics activity of APE1 mutants on ds dF:dC oligonucleotide. Data are expressed
as mean ± SD of three independent technical replicas. Standard deviation values were always <10% of the mean of the experimental points. (C) Graph
illustrating the time-course kinetics activity of APE1 mutants on ds rOH:dC oligonucleotide. Data are expressed as mean ± SD of three independent
technical replicas. Standard deviation values were always <10% of the mean of the experimental points.
Table 1. Kinetic parameters for APE1 endonuclease activity on different substrates
[APE1] (× 10−3 nM) Substrate KM (nM) VMAX (nM/min) kCAT (min−1) kCAT/KM (min.nM)−1
75 ds dF:dC 14.2±6.98 0.95±0.33 12.7±4.39 0.95±0.16
3.125 ds rOH:dC 158±41.79 12.66±3.71 4054±1191.8 26±1.96
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Figure 5. APE1 knock down in human cells impairs the processing of an
rAP site embedded in a duplex DNA substrate. (A) Graph illustrating the
time-course kinetics activity of NCE on ds dF:dC in control and APE1-
knocked down conditions. Data are expressed as mean ± SD of three in-
dependent technical replicas. Standard deviation values were always less
than 10% of the mean of the experimental points. (B) Graph illustrating
the time-course kinetics activity of NCE on ds rOH:dC oligonucleotide in
control and APE1-knocked down conditions. Enzymatic reaction was per-
formed at 37◦C in APE1-buffer with 10 ng of NCE. Data are expressed as
mean ± SD of three independent technical replicas.
nuclear cell extracts in which APE1 was knocked-down
through specific siRNAs (Supplementary Figure S3A), as
explained in Materials and Methods. The endonuclease
activity of APE1-kd (siAPE1) cell extracts, was reduced
on both ds dF:dC (Figure 5A and Supplementary S4D)
and ds rOH:dC (Figure 5B and Supplementary S4D), as
compared to its respective control SCR-treated extracts. As
western blot analysis shows (Supplementary Figure S3A),
the expression of APE1 protein did not exert any effect on
the expression of RNase H2 protein itself, demonstrating
that the observed reduction of the processing activity
of the abasic rNMP-containing substrate, observed with
APE1-kd cell extracts, was likely due to the reduced
expression of the APE1 protein. We further examined
the specificity of the enzymatic activity of APE1 using
the tetrahydrofuran ribonucleotide mimicking an abasic
residue. We tested the activity of the APE1 E96A mutant
to cleave at a ds rF:dC substrate compared to that of
APE1 WT (Figure 6A). As a control, the activity on
the ds dF:dC substrate was also analyzed. As it can be
observed, mutant E96A showed a reduced cleavage on
the ds rF:dC substrate. Indeed, APE1 WT gave a 96% of
cleavage at 5 and 10 nM (lanes 2 and 3), whereas mutant
APE1 E96A had 32% cleavage at 5 nM and 38% at 10 nM
(lanes 5 and 6). Cleavage of ds rF:dC by APE1 WT was
89% at 5 nM and 90% at 10 nM (lanes 8 and 9), and there
was minimal activity for APE1 E96A on the ds rF:dC sub-
strate in the same conditions (lanes 11 and 12). Moreover,
pre-treatment of cell extracts with 0.2 nM of Compound
#3 (i.e. N-(3-(benzo[d]thiazol-2-yl)-6-isopropyl-4,5,6,7-
tetrahydrothieno[2,3-c]pyridin-2-yl)acetamide)), a specific
APE1 endonuclease inhibitor (53,56), exerted a significant
inhibitory effect upon APE1 enzymatic activity on both
ds dF:dC in DNA and ds rF:dC substrates demonstrating
that the main enzymatic activity of cell extracts was due
to APE1 function (Figure 6, panels B and C).These data
demonstrate that human APE1 is the major enzyme
capable of specifically cleaving at abasic rNMPs in DNA
while being unable to process normal rNMPs, which are
the preferential substrates of RNase H2.
Human RNase H2 does not process an r8oxoG embedded in
a duplex DNA
An abasic site can be generated spontaneously or following
the processing of an oxidized lesion from a specific glyco-
sylase. While known glycosylases (such as OGG1) are re-
sponsible for this activity on 8oxo-dG, no enzyme is known
to be able to process the oxidized rG substrate. We then fo-
cused our attention on r8oxoG removal. The r8oxoG con-
taining oligonucleotide was in-house synthesized and, as
observed from MALDI-MS analysis and HPLC purifica-
tion (Supplementary Figure S5, panels A and B), the un-
desirable presence of secondary products of the chemical
synthesis of this substrate can be excluded. First of all, we
investigated whether human RNase H2 was able to recog-
nize and cleave at r8oxoG site using an oligonucleotide con-
taining this type of lesion called ds r8oxoG:dC (Figure 7A,
see also Supplementary Table S1, Supplementary Figure
S1). In these experiments, we always compared the specific
enzymatic activity of RNase H2 with that exerted on the
canonical ds rG:dC substrate, as positive control, and using
the ds d8oxoG:dC oligonucleotide as negative control. As
Figure 7B shows, while the ds rG:dC oligonucleotide was
efficiently processed by RNase H2, the same activity was
not observed for ds r8oxoG:dC. As expected, the d8oxoG-
containing oligonucleotide was not cleaved by RNase H2.
These data confirm that RNase H2 was not able to pro-
cessmodified rNMPs embedded inDNA. Similarly, we con-
firmed these data using RNase H2-kd nuclear extracts from
HeLa cells. As expected, control nuclear extracts (Scramble)
displayed a time-dependent endoribonuclease activity on
ds rG:dC, whereas the down regulation of RNase H2 pro-
tein expression (siRNase H2) was associated with a marked
reduction of the endoribonuclease activity on the same sub-
strate (Figure 7C). On the contrary, once we tested the abil-
ity of the nuclear extracts on ds r8oxoG:dColigonucleotide,
we found only a weak endoribonuclease activity on it (see
the band indicated by an asterisk), which was not affected
by RNase H2 silencing (Figure 7C). These data support the
conclusion that the r8oxoG site in DNA is not recognized
by human RNase H2.
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Figure 6. Recombinant human APE1 efficiently processes a tetrahydrofuran ribonucleotide mimicking an abasic residue site (rF) embedded in a duplex
DNA substrate. (A) Cleavage result of 10 nM of 32P double-stranded oligonucleotides ds dF:dC or ds rF:dC substrates with different concentrations of
APE1 WT protein (lanes 1–3 and 7–9) and mutant APE1 E96A protein (lanes 4–6 and 10–12) at 37◦C for 1 h in APE1-reaction 1× buffer containing 50
mMTris–HCl pH 7.5, 50 mMKCl, 10 mMMgCl2, 0.001 mg/mLBSA and 0.05% Triton X-100. First lane on the left, M is a ssDNA ladder (barely visible)
and the black arrows on the left show specific band sizes. Both oligonucleotides were incubated with 0 nM (lanes 1,4,7,10), 5 nM (lanes 2,5,8,11) or 10 nM
(lanes 3,6,9,12) of APE1 WT protein (lanes 1–3 and 7–9) or mutant E96A protein (lanes 4–6 and 10–12), respectively. The percentages of cleavage of each
reaction are displayed below the image as enzymatic activity (%). (B) Cleavage result of 10 nM ds dF:dC or ds rF:dC radioactive substrates using 12.5 ng
of whole HeLa cell extracts untreated (lanes 1, 3) and treated (lanes 2, 4) with 0.20 nM of Compound #3, a specific APE1-endonuclease inhibitor, at 37◦C
for 10 min. The black arrows on the left of the gel image indicate the size of uncut and cut substrates following denaturation. The cleavage percentage of
this experiment is displayed below the image as enzymatic activity (%). (C) Histograms showing data from four independent experimental replicas shown
in panel (B) with ranges as bars. P values of <0.05 are marked by asterisk. WCE, whole cell extracts.
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Figure 7. Human RNase H2 is not able to process an r8oxoG site embedded in a duplex DNA substrate. (A) Scheme of ds DNA 25-mer substrates (single
strand (ss) oligonucleotide annealed to ss dC containing- or ss dA containing-complementary oligonucleotide) containing a d8oxoG, r8oxoG and dF site
in the 13th position. The ‘IRD700’ and ‘IRD800’ in green indicates IRDye 800 phosphoramidite and IRDye700 phosphoramidite dye tagged at the 5′
end. (B) Representative denaturing polyacrylamide gel of oligonucleotides (25 nM) incision by human recombinant RNase H2 (5 fmol). Reaction was
performed in RNase H2-buffer (20 mM Tris–HCl, 25 mMKCl, 0.1% BSA, 0.01% Tween20, 4 mMMgCl2, pH 7.4) at 37◦C. ds rG:dC and ds d8oxoG:dC
oligonucleotides were used as positive and negative controls, respectively. Time points are shown on the top of the figure. S indicates the substrate position,
while P indicates the product position. (C) Representative denaturing polyacrylamide gel of oligonucleotides (0.25 M) incision by nuclear HeLa cell
extracts (NCE). In order to discriminate the activity of RNase H2, 500 ng of NCE in which RNase H2 expression was previously knocked down through
specific siRNA (indicated as siRNase H2) were tested in comparison to control cells (Scramble) at different time points (minutes), shown on top of the
figure. The endoribonuclease activity detected for r8oxoG oligonucleotide was indicated with an asterisk on the right side of each panel. S indicates the
substrate position while P indicates the product position.
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OGG1 has neither lyase nor glycosylase activities on oxidized
rG substrate
We then tested whether enzymes of the BER pathway
may be involved in processing the r8oxoG substrate. To
this purpose, we used recombinant purified human OGG1
and APE1 proteins (Supplementary Figure S4A and S5C).
OGG1 protein belongs to the bi-functional glycosylases
family having both lyase and glycosylase activities on ox-
idized dG (57). We examined the processing activity of
OGG1 on r8oxoG substrate in comparison to the d8oxoG-
containing oligonucleotide, as a positive control. First, we
tested the ability of OGG1 to recognize an r8oxoG site
through electrophoretic mobility shift assay (EMSA). As
shown in Figure 8A, increasing amount of recombinant
OGG1 formed a stable retarded complex with the r8oxoG
oligonucleotide in a dose-dependent manner. As confirmed
in the data shown in Supplementary Figure S5E, OGG1
binding was specific for the modified r8oxoG- containing
oligonucleotide (lanes 2 and 3). Indeed, the same retarded
band was observed when the recombinant OGG1 was in-
cubated with the positive control ds d8oxoG:dC (lanes 11
and 12) but not with the negative controls: ds rG:dC (lanes
5 and 6) and ds dG:dC (lanes 8 and 9).
Furthermore, we tested the lyase activity ofOGG1on dif-
ferent substrates. Figure 8B shows that when we incubated
increasing amounts of recombinant protein for 30 min at
37◦C with different substrates, OGG1 was able to process
only the canonical substrate ds d8oxoG:dC in a dose re-
sponse manner (Supplementary Figure S5D), whereas no
lyase activity was apparent for any of the other substrates
used, including the ds r8oxoG:dC and the ds r8oxoG:dA.
Since OGG1 is the major glycosylase enzyme in the
BER pathway, coordinating with the downstream endonu-
clease APE1, which is able to recognize and process the
abasic site generated by the glycosylase activity of OGG1
(28,58,59), we measured its glycosylase activity on the same
substrates using recombinant purified APE1 (Figure 8C).
In this case, we co-incubated a fixed amount of recombi-
nant OGG1 with increasing amounts of APE1 for 30 min.
While OGG1 displayed a robust glycosylase activity on the
canonical ds d8oxoG:dC substrate, particularly in the pres-
ence of the APE1 protein, we detected only a weak activity
on ds r8oxoG:dC oligonucleotide (indicated by a single as-
terisk) (Figure 8D).Moreover, the presence of an additional
highermobility band, increasing as a function ofAPE1 con-
centration (indicated with a double asterisk) was observed
only in the case of the ds r8oxoG:dC substrate.We conclude
that OGG1 has neither lyase nor glycosylase activity on the
r8oxoG substrate, and that APE1 can weakly process this
substrate alone. AboutAPE1 activity, a detailed description
is explained in the next paragraph.
APE1 has a weak endo-/exo-nuclease activities on the
r8oxoG-containing substrate depending on Mg2+ concentra-
tion and on the presence of its N-terminal domain
Based on the above presented data, we then checked
whetherAPE1 ‘per se’ had any endoribonuclease activity on
ds r8oxoG:dC substrate (Figures 9 and 10). Compared to
the ds dF:dC substrate, APE1 displayed a modest, though
significant, processing activity on both ds r8oxoG:dC and
ds r8oxoG:dA oligonucleotides, while no activity was ob-
served in the case of the dG- and the d8oxoG-containing
substrates (Figure 9, panels A and B), as expected. As ob-
served above, the appearance of an additional faster migrat-
ing cleavage product (indicated by a double asterisk corre-
sponding to a 11-nt product in Figure 8D) was visible in
the case of the ds r8oxoG:dC substrate, which might be
associated with a recently identified 3′-exonuclease activ-
ity by the protein (42). We checked the occurrence of the
cleavage at the expected ribonucleotide sites, by oligonu-
cleotide sequences of increasing length, ranging from 10
to 16 nucleotides, as molecular markers (Supplementary
Figure S6A) and through alkaline hydrolysis experiments
(Supplementary Figure S6B). As it is visible (Supplemen-
tary Figure S6A), cleavage products of the ds r8oxoG:dC
oligonucleotide were of the expected size and comprised be-
tween 11- and 12-nucleotides and are thus compatible with
endonucleolytic cleavage occurring only at the 5′ side of
the lesion (fragment 12-nt long) and with a 3′-exonuclease
activity giving rise to the fragment of 11-nt long. In or-
der to exclude that the observed cleavage product was
due to the processing of a residual non-annealed oligonu-
cleotide possibly present after the annealing reaction, we in-
cubated APE1 protein with single stranded oligonucleotide
(ss r8oxoG) and compared the cleavage product with the
annealed oligonucleotide (ds r8oxoG:dC). Comparing the
result with both ss dF and ds dF:dC oligonucleotides, a
product was detectable only using the double stranded
oligonucleotides as substrates. No bands were observed us-
ing the ss r8oxoG oligonucleotide (Supplementary Figure
S6C) demonstrating the requirement for secondary struc-
tured oligonucleotide sequences for efficient enzymatic ac-
tivities by APE1. In contrast, using the oligonucleotide con-
taining the mismatched ds r8oxoG:dA, most of the frag-
ments produced after incision by the AP endonucleolytic
activity (indicated with a single asterisk) were not further
degraded by the exonucleolytic activity (Figure 9A). There-
fore, these data demonstrate that the APE1 enzymatic activ-
ity on the r8oxoG substrate requires a dsDNAmolecule and
exonuclease activity is dependent on the paired nucleotide,
possibly as a consequence of a different stereochemical ge-
ometry between the 8oxoG:A and the 8oxoG:C.
It has been previously demonstrated that the exonucle-
ase activity of APE1 strictly depends on salt concentra-
tions (60). We therefore tested whether the 3′-exonuclease
activity observed on the ds r8oxodG:dC shared some com-
mon features (in terms of dependence on the ionic strength
conditions) with the 3′-exonuclease activity on mispaired
DNA, as previously described (60). Firstly, we determined
the optimalMgCl2 (Figure 10A) andKCl (Figure 10B) con-
centrations required for the 3′-exonuclease activity. Indeed,
the 3′-exonuclease activity was present up to a concentra-
tion of 2 mM MgCl2. An inhibitory effect was apparent at
MgCl2 concentrations above 4 mM. At the same time, the
3′-exonuclease activity was poorly affected at KCl concen-
tration equal to 100mM.These results are in line with previ-
ous data on 3′-mispairedDNA (60) and suggest that the ob-
served 3′-exonuclease activity strongly depends on the elec-
trostatic interaction of APE1 with the substrate during the
cleavage reaction and with the role of Mg2+ ions.
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Figure 8. Human OGG1 has neither lyase nor glycosylase activities on r8oxoG-containing oligonucleotide. (A) Representative native EMSA polyacry-
lamide gel of OGG1 binding on ds r8oxoG:dC oligonucleotide (25 nM) is shown. The ‘Bound’ arrow indicates the retarded complex between OGG1 and
the probe whereas the ‘Free’ arrow the unbound substrate. Amounts of OGG1 protein, expressed in pico moles, are shown on the top of the figure. Reac-
tions were performed as explained in ‘Materials andMethods’ section. (B) Representative denaturing polyacrylamide gel of lyase activity of human OGG1
on different duplex DNA oligonucleotides (25 nM). Doses of OGG1 protein expressed in femto moles are shown on the top of the figure. Reactions were
performed in OGG1-buffer (20 mM Tris–HCl, 100 mM KCl, 0.1% BSA, 0.01% Tween20, pH 7.4) at 37◦C for 30 min. S indicates the substrate position,
while P indicates the product position. (C) Representative denaturing polyacrylamide gel of incision by different doses of APE1 co-incubated with a fixed
amount of OGG1 (3.125 nM) on different duplex DNA oligonucleotides (25 nM) in order to investigate glycosylase activity of OGG1. Different doses of
APE1 protein, expressed in femtomoles, are shown on top of the figure. Reactions were performed in a buffer containing 20 mM Tris–HCl, 100 mMKCl,
0.1% BSA, 0.01% Tween20, pH 7.4 at 37◦C for 30 min. S indicates the substrate position while P indicates the product position. Moreover, at the right of
the panel, a longer product of about 12 nucleotides is indicated by an asterisk whereas a smaller one of 11 nucleotides is indicated by a double asterisk.
(D) Histograms represent the dose response of OGG1 glycosylase activity on ds d8oxoG:dC and paired and mismatched ds r8oxoG oligonucleotides.
ds d8oxoG oligonucleotide was used as a positive control whereas ds dG:dC and ds rG:dC oligonucleotides were used as negative controls. The activity is
reported as percentage of substrate converted to product. Data are expressed as mean ± SD of three independent technical replicas.
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Figure 9. Human APE1 shows a weak endo- and a 3′-exonuclease activities on r8oxoG substrate. (A) Representative denaturing polyacrylamide gel of
APE1 incision on different duplex DNA oligonucleotides (25 nM), in which ds dF:dC oligonucleotide was used as a positive control, whereas ds dG:dC
and ds rG:dC oligonucleotides were used as negative controls. The doses of APE1 protein used, expressed in femtomoles, are shown on the top of the figure.
On the right side, a schematic representation of the cleavage products, showing the position of the ribonucleotide (red box with R) embedded in the DNA
oligonucleotide and theAPE1 cleavage on it, producing a longer product of about 12 nucleotides (*) and a smaller one of 11 nucleotides (**). Reactions were
performed in APE1-buffer containing 20 mM Tris–HCl, 100 mM KCl, 0.1% BSA, 0.01% Tween20, pH 7.4 for 30 min at 37◦C. S indicates the substrate
position while P indicates the product position. (B) Relative graph indicates a dose–response APE1 activity on paired and mismatched ds r8oxoG:dC
oligonucleotide in comparison to ds dF:dC positive control. Data are expressed as mean ± SD of three independent technical replicas.
After choosing the optimal salts conditions, in which
both endo- and exo- activities of APE1 (100 mMKCl and 1
mMMgCl2) are present, we then evaluated whether the en-
zymatic activity of APE1 on ds r8oxoG:dC was dependent
on the same catalytic site responsible for the endonuclease
activity observed on abasic dsDNA and abasic rNMP. To
this aim, the enzymatic activity of the E96A mutant was
compared to that of the WT protein (Supplementary Fig-
ure S6D). These data demonstrate that the APE1 E96A
mutant has a reduced endoribonuclease activity showing
no 3′-exonuclease activity over the ds r8oxoG:dC substrate.
Due to the effect of salt concentration on this latter ac-
tivity, we also tested the enzymatic activity of the APE1
N33 deletion mutant (Supplementary Figure S6D). In-
terestingly, while this protein retained the endoribonuclease
activity of the WT protein, its 3′-exonuclease activity was
abolished. Moreover, treatment with APE1 inhibitor Com-
pound #3 confirmed that the catalytic site responsible for
the endonuclease activity is also responsible for the endori-
bonuclease activity over the r8oxoG substrate (Supplemen-
tary Figure S6E). These results show that APE1 has a weak,
though significant, endoribonuclease activity on r8oxoG
substrates with an additional specific 3′-exonuclease activ-
ity dependent on: (i) the kind of pair: i.e. ds r8oxoG:dC or
ds r8oxoG:dA; (ii) salt concentrations (i.e. Mg2+); (iii) the
presence of the 33 N-terminal domain.
Overall, our data demonstrate that BER enzymes but not
RER are involved in the processing of non-canonical rN-
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Figure 10. Human APE1 activities on r8oxoG substrate depend on mono- and di-valent cations. (A) Representative denaturing polyacrylamide gel of
APE1 (5 nM) incision on ds r8oxoG:dC oligonucleotide under different MgCl2 concentrations that is expressed in mM (top) performing a reaction long
30 minutes in APE1 buffer. S indicates the substrate position while P indicates the product position. Moreover, at the right of the panel, a longer product
of about 12 nucleotides is indicated by an asterisk whereas a smaller one of 11 nucleotides is indicated by a double asterisk Also shown on the right is a
schematic representation of the cleavage products, showing the position of the ribonucleotide (red box with R) embedded in the DNA oligonucleotide and
the APE1 cleavage on it, producing a longer product of about 12 nucleotides (*) and a smaller one of 11 nucleotides (**). Relative graph shows the ratio
between two products obtained as a function ofMgCl2 concentration (bottom). (B) Representative denaturing polyacrylamide gel of APE1 (5 nM) incision
on ds r8oxoG:dC oligonucleotide under different KCl concentrations in combination with two different MgCl2 concentrations, 1 mM and 10 mM (top)
performing a reaction long 30 min in a buffer containing 20 mM Tris–HCl, 0.1% BSA, 0.01% Tween20, pH 7.4. S indicates the substrate position, while P
indicates the product position. Moreover, at the right of the panel, a longer product of about 12 nucleotides is indicated by an asterisk whereas a smaller
one of 11 nucleotides is indicated by a double asterisk. Relative graph shows product levels in association with different salts concentrations (bottom).
MPs, such as abasic or oxidized, incorporated in DNA. Be-
cause the repair pathway catalyzed byAPE1 toward the oxi-
dized rG is fundamentally different from that of BER, since
no bases are excised, we can conclude that the observed ef-
fect could be ascribed to an alternative damage-specific en-
donuclease initiated repair pathway, previously referred to
as either alternative excision repair (AER) or nucleotide in-
cision repair (NIR) (reviewed in (61,62)).
APE1 and RNase H2 do not biochemically and functionally
interact in human cells
To support the functional independence between BER and
RER, we tested whether APE1 and RNase H2 proteins
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functionally interact.We tested whether this hypothesis was
confirmed in HeLa cells transfected with siRNAs specific
for APE1 and RNase H2 mRNAs to knock down the cor-
responding endogenous proteins. Whole cell extracts were
prepared as explained in Materials and Methods section,
and western blotting analysis was used to check the effec-
tive protein down regulation (Supplementary Figure S7A).
Then, we checked the ability of APE1 and RNase H2 from
cell extracts to recognize the ds r8oxoG:dC substrate. We
performed EMSA with cell extracts from control (Scram-
ble) and APE1-kd (siAPE1) or RNase H2-kd (siRNase H2)
cells. As demonstrated in Supplementary Figure S7B, incu-
bation of cell extract from control cells displayed a retarded
band containing APE1-complex, as also demonstrated by
supershift EMSA experiments with anti-APE1 specific an-
tibody (Supplementary Figure S7, panels C and D). The in-
tensity of the retarded complex was decreased upon APE1-
kd (siAPE1) (Supplementary Figure S7B, lane 4) and upon
the double APE1/RNase H2-kd (siAPE1 + siRNase H2)
(lane 6) but not upon RNase H2 silencing alone (siRNase
H2) (lane 5), confirming that APE1 is involved in a protein
complex able to recognize r8oxoG damage in which RNase
H2 is not present.
DISCUSSION
Increased body of evidence supports the notion that incor-
poration of rNMPs in DNA is a frequent phenomenon,
having profound detrimental effects on genome stability of
both prokaryotes and eukaryotes (1,2,63,64). In humans, as
well as in yeast and bacteria including Archaea, the main
processing pathway responsible for repairing of these le-
sions is the RER pathway, which involves the RNase H2
enzyme (65,66). RNase H2 importance in higher organisms
is testified by its essentiality for embryonic development in
mouse (67). Moreover, RNase H2 mutations in humans are
causally linked to the onset of AGS, a rare autoimmune
inflammatory disease (68,69). It can be hypothesized that
among the many millions rNMPs that are introduced in the
mammalian genome per cell cycle (3), not only canonical
rNMPs are incorporated but also damaged rNMPs (such
as abasic and oxidized). Indeed, like deoxyribonucleotides,
rNMPs are also susceptible to oxidative insults (5,70), and
a significant generation of abasic sites formation has been
demonstrated upon RNA oxidation and alkylation (71).
While the role of RNase H2-initiated RER mechanism of
DNA repair in recognizing and cleaving rNMPs embedded
in DNA is well established (3,15), nothing is known regard-
ing the DNA repair pathways involved in the removal of
damaged rNMPs.
BER is the main mechanism coping with the repair of
non-distorting single-base lesions, such as abasic sites and
oxidized bases (27). Interestingly, emerging literature, in-
cluding ours, pointed to a new function of BER in RNA
quality control surveillance and RNA-decay with the func-
tions of SMUG1, PARP1 and APE1 in RNA processing
(38,72). At present, however, there is no evidence that BER
may cope with the removal of rNMPs fromDNA. Identify-
ing whether BER may target unmodified and/or modified
rNMPs in DNA is important to better understanding the
mechanism of genotoxicity of oxidative stress and the im-
pact of BER defects in human disease, cancer mechanisms,
and for the development of new anticancer strategies.
In this work, we demonstrate that an rAP site embedded
in DNA is targeted by APE1 of BER rather than RER in
eukaryotic systems (Figure 11A). We have found that eu-
karyotic RNase H2 enzymes from yeast, mouse and hu-
man, and from human cell extracts are unable to process
rAP sites in DNA, whereas recombinant human APE1 is
able to efficiently cleave this type of damage (Figures 2 and
3). APE1 processes the rAP site as efficiently as the canoni-
cal deoxy-abasic site as measured by kinetic data (Table 1).
Data using catalytic inactive APE1 mutants (E96A) clearly
demonstrate that the endonuclease active site of APE1 is
required to perform the endoribonuclease activity on a ri-
bose abasic site in dsDNA. Differently, the cleavage activity
of the 33N-terminal truncated mutant, which does not im-
pact the catalytic function of the enzyme but is involved in
the release of the product upon cleavage (48), is compara-
ble to that of wild-type APE1. This last result demonstrates
that the unstructured N-domain is dispensable for the enzy-
matic reaction on the abasic ribonucleotide site. Moreover,
using HeLa nuclear cell extracts that were siRNA-depleted
of APE1 or RNAse H2 proteins, we showed that the pro-
cessing activity of the rAP site in DNA depends only on
the presence of APE1 and not on RNase H2. These results
highlight a new role of APE1 in repairing rAP sites embed-
ded in DNA, demonstrating that the catalytic site of APE1
and the mechanism of product release is similar to that of
the canonical deoxy-substrate.
rAP sites embedded in DNA may be generated by spon-
taneous hydrolysis or by the action of an unknown glyco-
sylase on oxidized rNMPs, such as r8oxoG. Furthermore,
a potentially significant, yet poorly characterized, source of
rNMPs incorporated inDNA is the oxidative stress. rNMPs
were shown to form during oxidative DNA damage both in
vitro and in vivo (5). Therefore, it is also possible that abasic
and oxidized DNA is converted into RNA. It was estimated
that spontaneous depurination occurs 1,000 times slower in
RNA than DNA (73). For example the rate of depurina-
tion in DNA under physiological conditions is estimated to
be 1 out of 100 000 purines every cell cycle. This rate gives
10 000 abasic sites per day in human cells (74). Considering
the remarkable abundance of rNMPs in DNA, which could
be as many as 600 000 rNMPs in budding yeast genomic
DNA, and therefore a factor of 250 higher in mammalian
genomic DNA (150 000 000) (3), i.e. >300 millions in the
human diploid DNA per cell cycle, it is not unrealistic to
anticipate that cells may contain a non-negligible number
of rAP sites inDNA, or oxidized rNMPs. Interestingly, aba-
sic RNA results significantly more stable than abasic DNA,
suggesting that specific enzymatic mechanisms should exist
in vivo to cope with this harmful lesion (75). In addition,
in conditions of oxidative DNA damage, such as in can-
cer cells, the likelihood of such base modifications can in-
crease. Moreover, recent studies already suggested that r8-
oxoGTP is formed in vivo under oxidative stress conditions
and may be incorporated during replication into DNA by
S. pombe,M. smegmatis and human (34–36). Moreover, the
introduction of r8oxoG inDNA can be catalyzed by human
DNA Pol (36). However, the level and function of Pol
in cells are highly regulated by complex signaling mecha-
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Figure 11. Model for repair of oxidized rNMPs and rAP sites embedded in DNA by APE1. (A) 8oxo-ribonucleotides could be generated in the cellular
nucleotide pool or even when they are already incorporated in DNA as a result of an oxidation of the sugar (1) and/or the base (2). After the evidence
that human RNase H2 is not able to process an oxidized rNMP embedded in DNA, we found that APE1 shows a weak but significant activity on it (3).
Similarly, RNase H2 does not process an rAP embedded in DNA, which could be generated spontaneously or by the r8oxoG processing, and again APE1
possesses a strong activity on this type of damage (4). Because APE1 activity on 8oxo-ribonucleotides in DNA is low, we hypothesize that other proteins
(some glycosylases?) may participate in their repair. (B) Structural models with the active site of RNase H2 andAPE1 with an rNMP or an rAP.T. maritima
(left) and human APE1 (right) is in a complex with DNA having a single rNMP or single abasic residue, respectively. DNA is indicated in blue, while the
single rNMP and the abasic residues are shown in red as sticks. The arrows points towards ribose or G base or abasic sites in the panels. Proteins are shown
in green except for three of the several regions on APE1 that engulf the abasic sugar which are in magenta. PDB for RNase H2 is 303-F; for APE1 as
1DEW (92).
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nism and interactome networks (76). Therefore, the proba-
bility of r8oxoG incorporation into genomic DNA by Pol
is still a question under debate, which needs further exper-
imental proof. Spontaneous formation of rAP sites being
a rare event, it is a key question to find activities produc-
ing rAPs following processing of oxidized rNMPs in DNA.
In addition, a possible RER and BER involvement in re-
moval of r8oxoG from DNA has been proposed in other
reports (36,77). Work in our laboratory is ongoing along
these lines to address these fundamental issues. Considering
these observations, we focused our attention on which BER
protein, if any, may be involved in recognition and cleav-
age of oxidized rNMPs (r8oxoG) embedded in DNA. First,
we tested the RNase H2 activity on r8oxoG substrate (Fig-
ure 7). Similarly to results with the abasic rNMP in DNA
our data clearly demonstrate that RER is not involved in
processing of oxidized rNMPs embedded in DNA. Based
on these findings, we explored a potential role of the BER
pathway. First, we showed that the human OGG1, the main
glycosylase enzyme able to recognize and repair oxidized
dG through its lyase and glycosylase activities, has neither
a lyase nor a glycosylase activity on an oxidized rG site em-
bedded in a DNA substrate, despite its ability to efficiently
bind the oxidized substrate (Figure 8), in agreement with
recent findings (77). Interestingly, we discovered that APE1
has a weak endoribonuclease activity on r8oxoG site em-
bedded in a DNA substrate, and shows a 3′-exonuclease
activity (Figures 9 and 10), similarly to the 3′-exonuclease
activity on DNA demonstrated previously (52,54). In line
with previous results, the 3′-exonuclease activity of APE1 is
strictly dependent on Mg2+ concentration and on the pres-
ence of the first 33 aminoacids. The importance of the N-
terminal domain is to be attributed to different reasons: (i)
it bears the majority of the positive charges of APE1; (ii)
is the target of the main post-translational modifications
of the protein (i.e. acetylation, ubiquitination, proteolysis);
(iii) is involved in modulating the interaction with different
protein partners and finally (iv) may modulate the catalytic
rate, probably acting on the koff of the catalytic reaction due
to increased speed of product release (37,48,78). These un-
expected results, which suggest that APE1 3′-exonuclease
activity strongly depends on the electrostatic interaction of
APE1, involving its unstructured N-terminal domain, with
the substrate (52), may be explained on the basis of the
previously characterized ability of APE1 to process some
particular structured RNA species in a specific manner
(37).The activity of APE1 on r8oxoG embedded in DNA
does not hide the possibility that a similar activity could be
exerted on RNA molecules too. This finding could repre-
sent the first demonstration of an enzyme able to recognize
and process oxidized RNA (78). To date, RNA oxidation
has been shown to exert detrimental physiological effects
and to be a common feature in different human pathologies
ranging from ageing to neurodegenerative and cancer dis-
eases (79). For instance, oxidized RNA (80) or RNA con-
taining abasic sites (75) show inhibitory effects on reverse
transcriptase activity, whereas oxidized mRNA (81,82) or
mRNA with abasic sites (83) exhibit compromised transla-
tion activity as well as translation fidelity (84). The weak
endo- and 3′-exonuclease activities on r8oxoG- contain-
ing substrate and their dependence onMg2+-concentrations
and on the presence of the first N-terminal domain
residues of APE1 are fully in agreement with the pre-
viously described nucleotide incision repair (NIR) func-
tion by APE1 on several oxidized substrates, such as: 5,6-
dihydro-2′-deoxyuridine, 5,6-dihydrothymidine, 5-hydroxy-
2’-deoxyuridine, 5-hydroxycytosine (43–45). Notably, the
limited activity obtained in the experimental conditions
we used (also after changing the pH conditions, data not
shown) are in agreement with previous reports on the NIR
function by APE1 on some particular substrates such as
the dG:dG and the 5OH-dC:dG (44). In addition, the bio-
chemical characterization throughMALDI-MS andHPLC
analyses we performed (Supplementary Figure S5 panels A
and B) may be suggestive for the existence of an equilib-
rium between different conformational species of r8oxoG
dsDNA, excluding any possible bias due to contaminant
present in the oligonucleotide used for the assays. There-
fore, these findings underscore the importance of identify-
ing the enzyme(s) responsible for the recognition and effi-
cient processing of the r8oxoG substrate, in order to further
extend our studies and our understanding of this hot scien-
tific topic.
We observed that OGG1 is unable to process the r8oxoG
substrate, while being perfectly able to specifically bind it,
similar to what recently published by Sassa et al. (77). At
present, it is possible to speculate that though the base-
flipping occurs, the enzymes is unable to hydrolyze the N-
glycosidic bond and has no lyase activity maybe as a conse-
quence of the steric hindrance with the 2′OH of the ribose
which renders the C1′ unavailable for the nucleophilic at-
tack by the catalytic site. Differently from our results, Sassa
et al. found no enzymatic activity by APE1. This discrep-
ancy with our results may be due to the different experi-
mental conditions for the enzymatic assays, i.e. higherMg2+
concentrations and the use of a small amount of EDTA,
both aspects already demonstrated to strongly affect the
APE1 enzymatic activity on the r8oxoG substrate. A com-
parative experiment we performed (Supplementary Figure
S8) was indeed supportive of this hypothesis, reinforcing the
importance of the experimental conditions when studying
the non-canonical functions of APE1 protein. Interestingly,
Sassa et al. showed that the commercially available prokary-
otic RNase HII preserves the ability to remove an oxidized
rNMP in aDNAduplex. Contrary to these results, our find-
ings show that eukaryotic RNase H2 is completely inactive
on a substrate containing an oxidized rNMP. These data
suggest that the ability to process r8oxoG in DNA has been
lost during evolution and deserves further studies.
To explain why APE1 recognized the abasic rNMP in
DNAandRNaseH2 did not, we compared themodel struc-
tures of DNA with an rNMP or an rAP site in the RNase
H2 and APE1 active site, respectively (Figure 11B). RNase
H2 recognizes the RNA-DNA junction with the substrate
participating in catalysis. Prior to incision by RNase H2,
the rNMP base is hydrogen bonded to the complementary
DNA strand base (85). If the rNMP is abasic, there is no hy-
drogen bonding to stabilize the complex required for RNase
H2. Rather, an orphan base on the complementary DNA
strand is present. We hypothesized that the lack of the hy-
drogen bonding between the abasic rNMP and the opposite
deoxyribonucleotide interferes with the capacity of RNase
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H2 to recognize an abasic rNMPand cleave it. Thus, the role
of recognizing and cleaving abasic rNMPs is not specific of
RNase H2. Differently from RNase H2, APE1 specifically
recognizes and cleaves an abasic distortion in DNA, and
basically engulfs the sugar-phosphate further distorting the
DNA (86), as seen in Figure 11B. Here, we predicted that
the ribose extra OH would have only minor influence on
the structure. Therefore, this could explain why the abasic
rNMP, like an abasic deoxyribonucleotide in DNA, was ef-
ficiently cleaved by APE1.
Experiments are underway in order to address if other
glycosylasesmay process oxidized rNMPs in order to gener-
ate rAP sites, which are then efficiently processed by APE1.
We previously demonstrated that APE1-defective cells have
increased oxidized rRNA content upon oxidative stress
(37). This result has now a molecular explanation in the
observed endoribonuclease activity of APE1 over r8oxoG
containing oligonucleotides and will deserve further atten-
tion in our future studies. Regarding the formation of aba-
sic ribonucleotides in DNA, this is still a matter of debate.
The existence of specific N-ribohydrolases, including the
toxin ricin, has been already documented (87) to be able to
generate abasic rNMPs in RNA molecules, besides sponta-
neous generation (71). A role for the YB-1 protein in rec-
ognizing oxidized ribonucleotides sites in RNA has also
been hypothesized (88), but no specific enzymatic mecha-
nisms able to remove the oxidized base has been described,
yet. The accumulation of the r8oxoG substrates, which oc-
curs on RNA upon silencing of APE1 expression, may thus
be explained under the assumption that enzymatic removal
of oxidized rNMPs may represent the limiting step in the
process. Besides its direct activity on r8oxoG, APE1 could
be stimulated by a glycosylase activity allowing a faster
turnover as demonstrated for DNA substrates (89). Work
is in progress along these lines to better inspect this mecha-
nism and the putative glycosylase enzymes involved. More-
over, since APE1 is overexpressed in different types of can-
cer, such as ovarian, gastro-esophageal, pancreatico-biliary,
lung and breast cancers (90,91), it would be interesting to
determine whether any correlation exists between its expres-
sion level and presence of modified rNMPs in cancers.
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